50% of moneycontrol users recommend buying Ipca Labs.
What's your call on Ipca Labs today?
Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||3218.40||0.96||3240.00||2420.00||54,830.54|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
RS Software (India) Recommended on Aug 12th 2014
Recommended price 430.00 | Peak from reco 829.30 82.59%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Ipca Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 9,859.94 crore.The company has reported a standalone sales of Rs 739.81 crore and a Net Profit of Rs 137.03 crore for the quarter ended Mar 2014.
The company management includes Premchand Godha - Chairman & Managing Director, Ajit Kumar Jain - Joint Managing Director, Pranay Godha - Executive Director, Prashant Godha - Executive Director, Babulal Jain - Director, Anand T Kusre - Director, Dev Parkash Yadava - Director, Ramakanta Panda - Director.
It is listed on the BSE with a BSE Code of 524494 and the NSE with an NSE Code of IPCALAB.
Its Registered office is at 48, Kandivli Industrial Estate, Kandivli (West), Mumbai,Maharashtra - 400067.
Their Registrars are Link Intime India Pvt. Ltd.